Company Overview of StemPath, Inc.
As of 2008, StemPath, Inc. went out of business. StemPath, Inc. develops therapeutic solutions for modulating body’s natural regenerative capacity and endogenously replacing damaged tissues with new tissues by intervention with small molecule and biological drugs. It develops peptide-based pharmaceuticals to stimulate heart and skeletal muscle regeneration. It offers cardiac and skeletal muscle myopathies. The company was founded in 2002 and is based in Ottawa, Canada.
501 Smyth Road
Ottawa, ON K1H 8L6
Founded in 2002
Key Executives for StemPath, Inc.
StemPath, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact StemPath, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.